trending Market Intelligence /marketintelligence/en/news-insights/trending/m9mhp7on26udz0cw4upzaw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Radius Health appoints chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Radius Health appoints chief medical officer

Waltham, Mass.-based biotechnology company Radius Health Inc. appointed Charles Morris as chief medical officer.

Morris was previously chief development officer at PsiOxus Therapeutics Ltd. He has also worked as the chief medical officer at Allos Therapeutics Inc., where he focused on the development of Folotyn in hematologic and solid tumors.

Jesper Hoiland, president and CEO of Radius Health, said that Morris' experience of late-stage drug trials and regulatory approvals will be vital during the phase 3 study of Elacestrant, or RAD1901, a treatment for breast cancer.

Radius Health develops hormone-based treatments for bone diseases and cancer.